EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

WCN26-9281 Experience with Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) in the Nephrology Department of Nishi-Kobe Medical Center

Hiroko Kakita, Tomoki Suetake, Kansei Otsuka, Yosuke Nakata, Koichiro Hagihara

Kidney International Reports · 2026-04 · 11 (4) · 106331

DOI: 10.1016/j.ekir.2026.106331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International Reports, 2026-04. Verfasst von Hiroko Kakita und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kakita, H., Suetake, T., Otsuka, K., Nakata, Y., & Hagihara, K. (2026). WCN26-9281 Experience with Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) in the Nephrology Department of Nishi-Kobe Medical Center. Kidney International Reports, 11(4), 106331. https://doi.org/10.1016/j.ekir.2026.106331

Vancouver

Kakita H, Suetake T, Otsuka K, Nakata Y, Hagihara K. WCN26-9281 Experience with Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) in the Nephrology Department of Nishi-Kobe Medical Center. Kidney International Reports. 2026;11(4):106331. doi:10.1016/j.ekir.2026.106331

BibTeX
@article{Kakita2026,
  author = {Kakita, Hiroko and Suetake, Tomoki and Otsuka, Kansei and Nakata, Yosuke and Hagihara, Koichiro},
  title = {WCN26-9281 Experience with Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) in the Nephrology Department of Nishi-Kobe Medical Center},
  journal = {Kidney International Reports},
  year = {2026},
  volume = {11},
  number = {4},
  pages = {106331},
  doi = {10.1016/j.ekir.2026.106331}
}
Kostenlos starten →